Julian Panés
Jefe de la UnidadFeatured publications
-
Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's disease
Authors:Reference: Gastroenterology 2019. -
Long-term Efficacy and Safety of Stem Cell Therapy (Cx601) for Complex Perianal Fistulas in Patients With Crohn's Disease
Authors:Reference: Gastroenterology 2018. -
Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis
Authors:Reference: Gut 2017. -
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials.
Authors:Reference: Gut 2017. -
Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
Authors:Reference: New England Journal Of Medicine 2017. -
Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease
Authors:Reference: Gut 2016. -
Commensal-Specific CD4(+) Cells From Patients With Crohn's Disease Have a T-Helper 17 Inflammatory Profile
Authors:Reference: Gastroenterology 2016. -
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: A phase 3 randomised, double-blind controlled trial
Authors:Reference: Lancet 2016. -
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease
Authors:Reference: Gut 2009.
Featured Projects
-
Dissecting the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE) the cellular basis of inflammatory bowel disease through single cell RNA sequencing (CELLBASE)
Principal investigator: Maria Azucena Salas Martinez, Julian Panes DiazFunder: Ministerio de Ciencia, Innovación y Universidades (Programa financiador competitivo)Code: RTI2018-096946-B-I00Duration: 01/01/2019 - 31/12/2021 -
Efficacy and safety of autologous hematopoietic stem cells transplantation for refractory Crohn's disease
Principal investigator: Elena RicartFunder: Instituto de Salud Carlos III (Programa financiador competitivo)Code: PI17/00513Duration: 01/01/2018 - 31/12/2020 -
IBD over time: Cellular Mechanisms in Crohn’s Disease Revealing new therapeutic avenues
Principal investigator: Maria Azucena Salas MartinezFunder: The Leona M and Harry B Helmsley Charitable TrustCode: HemsleyDuration: 02/01/2014 - 31/12/2017 -
New siRNA nanotherapy for inflammatory bowel diseases, targeting Janus kinase 3
Principal investigator: Fabrice Navarro, Maria Azucena Salas Martinez, Julian Panes DiazCode: NEW DEAL H2020Duration: 01/01/2017 - 31/12/2020 -
Autologous Hematopoietic Stem Cell Transplant in Crohn's Disease: genetic, Immune and Microbiome factors involved in disease control (TrIM)
Principal investigator: Julian Panes DiazCode: SAF 2012-33560Duration: 02/01/2013 - 31/12/2015